Emma Heckenberg is an analyst at Solas BioVentures, applying scientific and commercial expertise to healthcare investments. She holds a Ph.D. from Duke University and a B.S. from Drexel University.
At firms with a similar stage, sector and check size.
One email when Emma's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckEmma Heckenberg is an analyst at Solas BioVentures, applying scientific and commercial expertise to healthcare investments. She holds a Ph.D. from Duke University and a B.S. from Drexel University.
Solas BioVentures has not reported a check size. It invests at seed.
A warm intro from a founder Solas BioVentures backed works best. A short LinkedIn note with one line on traction is the next best route.
Last updated 2026-10-15. Is this you? Ask for a correction.